| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.41 | 2e-13 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.38 | 9e-12 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.29 | 5e-11 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-09 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-09 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-07 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-07 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-07 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.33 | 6e-07 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-06 |